secwatch.observer — SEC 8-K summary
======================================

Issuer:     GeoVax Labs, Inc. (GOVX)
CIK:        0000832489
Form:       8-K
Filed at:   2026-02-17T23:59:59+00:00
Accession:  0001437749-26-004392
Event type: other_material
Sentiment:  neutral
Materiality: 0.60
Item codes: 1.01, 3.02, 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

GeoVax raises ~$1M gross in registered direct offering priced at $2.31/share
----------------------------------------------------------------------------

- Offering of 432,902 shares (or pre-funded warrants) at $2.31/share; net proceeds ~$865,000.
- Concurrent private placement of Series A-1 and A-2 warrants for up to 432,902 shares each, exercisable at $2.31 after shareholder approval.
- Existing warrants for 236,000 shares amended: exercise price reduced from $4.35 to $2.31, subject to shareholder approval.
- Proceeds to fund R&D, manufacturing, clinical studies, and working capital.
- H.C. Wainwright acted as sole placement agent; closing occurred February 17, 2026.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/832489/000143774926004392/0001437749-26-004392-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/832489/000143774926004392/govx20260217_8k.htm
  HTML page:      https://secwatch.observer/filing/0001437749-26-004392

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer